Co-Moderator: Kenneth Hornbuckle, DVM, PhD – Eli Lilly and Company
### @@@ Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1360157###Co-Moderator###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Co-Moderator: Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers @@@ Christine E. Hallgreen, PhD – Copenhagen Centre for Regulatory Science, University of Copenhagen ### 1062920###Co-Moderator###Associate professor###Copenhagen Centre for Regulatory Science, University of Copenhagen###Co-Moderator: Christine E. Hallgreen, PhD – Copenhagen Centre for Regulatory Science, University of Copenhagen
###Presenting Author: Odile Sheehy, MSc (she/her/hers) – Research Centre - CHU Sainte-Justine
### she/her/hers @@@ Sherif Eltonsy, PhD – University of Manitoba ### 1357974###Co-Author###Assistant Professor###University of Manitoba###Co-Author: Sherif Eltonsy, PhD – University of Manitoba
### @@@ Steven Hawken, PhD – Ottawa Hospital Research Institute ### 1991313###Co-Author###Senior Scientist###Ottawa Hospital Research Institute###Co-Author: Steven Hawken, PhD – Ottawa Hospital Research Institute
### @@@ Padma Kaul, PhD, PhD – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept ### 1991314###Co-Author###Professor###University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept###Co-Author: Padma Kaul, PhD, PhD – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept
### @@@ Brandace Winquist – University of Saskatchewan ### 1991328###Co-Author######University of Saskatchewan###Co-Author: Brandace Winquist – University of Saskatchewan
### @@@ Olesya Barrett – Alberta Health Services, AHS Data & Analytics ### 1991315###Co-Author######Alberta Health Services, AHS Data & Analytics###Co-Author: Olesya Barrett – Alberta Health Services, AHS Data & Analytics
### @@@ Anamaria Savu – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept ### 1991316###Co-Author###Biostatistician###University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept###Co-Author: Anamaria Savu – University of Alberta - Faculty of Medicine & Dentistry - Medicine Dept
### @@@ Roxana Dragan – University of Manitoba ### 1991317###Co-Author######University of Manitoba###Co-Author: Roxana Dragan – University of Manitoba
### @@@ Michael Pugliese, MSc – OHRI (ICES uOttawa) ### 1991318###Co-Author###Research analysts###OHRI (ICES uOttawa)###Co-Author: Michael Pugliese, MSc – OHRI (ICES uOttawa)
### @@@ Sasha Bernatsky, MD, PhD – McGill University, Dept. of Medicine and CORE ### 1358207###Co-Author###Professor of medicine ###McGill University, Dept. of Medicine and CORE###Co-Author: Sasha Bernatsky, MD, PhD – McGill University, Dept. of Medicine and CORE
### @@@ Jessica Gorgui, PhD (she/her/hers) – Research Centre - CHU Sainte-Justine ### 1991319###Co-Author###Pharmacoepidemiologist###Research Centre - CHU Sainte-Justine###Co-Author: Jessica Gorgui, PhD (she/her/hers) – Research Centre - CHU Sainte-Justine
### she/her/hers @@@ Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal ### 1302804###Co-Author###Professor Researcher###University of Montreal###Co-Author: Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal
### she/her/hersCo-Moderator: Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis
### she/her/hers @@@ Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute ### 1061396###Co-Moderator###VP Epidemiology###Research Triangle Institute###Co-Moderator: Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute
###Presenting Author: Phyo Than T. Htoo, MD, PhD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1655578###Co-Author###Senior Research Specialist ###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### he/him/his @@@ Deborah Wexler, MD, MSc – MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA ### 1360566###Co-Author######MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA###Co-Author: Deborah Wexler, MD, MSc – MGH Diabetes Center, Division of Endocrinology, Dept of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
### @@@ Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1302713###Co-Author###Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###Co-Author: Robert J. Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Niklas Schmedt, DrPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany ### 1991321###Co-Author######Boehringer Ingelheim International GmbH, Ingelheim, Germany###Co-Author: Niklas Schmedt, DrPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany
### @@@ Anouk Déruaz-Luyet, PhD, MPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany ### 1360567###Co-Author######Boehringer Ingelheim International GmbH, Ingelheim, Germany###Co-Author: Anouk Déruaz-Luyet, PhD, MPH – Boehringer Ingelheim International GmbH, Ingelheim, Germany
### @@@ Lisette Koeneman, MD – Lilly Deutschland GmbH, Bad Homburg, Germany ### 1655588###Co-Author######Lilly Deutschland GmbH, Bad Homburg, Germany###Co-Author: Lisette Koeneman, MD – Lilly Deutschland GmbH, Bad Homburg, Germany
### @@@ Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1655332###Co-Author######Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Julie M. Paik, MD, ScD – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1360380###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###Co-Author: Elisabetta Patorno, MD, MPH, DrPH (she/her/hers) – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### she/her/hersPresenting Author: Yujia Li, MS – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
### @@@ Hui Shao – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy ### 1991119###Co-Author######Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy###Co-Author: Hui Shao – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
### @@@ Yi Guo – Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida ### 1991480###Co-Author######Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida###Co-Author: Yi Guo – Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida
### @@@ Yongkang Zhang, PhD – Department of Population Health Sciences, Weill Medical College of Cornell University ### 1991481###Co-Author###Assistant Professor###Department of Population Health Sciences, Weill Medical College of Cornell University###Co-Author: Yongkang Zhang, PhD – Department of Population Health Sciences, Weill Medical College of Cornell University
### @@@ Vivian Fonseca – School of Medicine, Tulane University ### 1991482###Co-Author######School of Medicine, Tulane University###Co-Author: Vivian Fonseca – School of Medicine, Tulane University
### @@@ Lizheng Shi – School of Public Health and Tropical Medicine, Tulane University ### 1991483###Co-Author######School of Public Health and Tropical Medicine, Tulane University###Co-Author: Lizheng Shi – School of Public Health and Tropical Medicine, Tulane University
### @@@ Jiang Bian – University of Florida ### 1658680###Co-Author######University of Florida###Co-Author: Jiang Bian – University of Florida
### @@@ Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety###Co-Author: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
### @@@ Serena Jingchuan Guo – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy ### 1659293###Co-Author###Assistant Professor###Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy###Co-Author: Serena Jingchuan Guo – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy
###Presenting Author: Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill, Department of Epidemiology
### @@@ Virginia Pate, MS – UNC Chapel Hill Gillings School of Global Public Health ### 1358426###Co-Author###Analyst###UNC Chapel Hill Gillings School of Global Public Health###Co-Author: Virginia Pate, MS – UNC Chapel Hill Gillings School of Global Public Health
### @@@ John Buse, MD – UNC Chapel Hill School of Medicine ### 1991568###Co-Author######UNC Chapel Hill School of Medicine###Co-Author: John Buse, MD – UNC Chapel Hill School of Medicine
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
### @@@ Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Co-Author: Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### he/him/hisPresenting Author: Joe B.B Silva, ScM (he/him/his) – Brown University School of Public Health
### he/him/his @@@ Chanelle J. Howe, PhD – Brown University School of Public Health ### 1660183###Co-Author###Associate Professor###Brown University School of Public Health###Co-Author: Chanelle J. Howe, PhD – Brown University School of Public Health
### @@@ John W. Jackson, PhD – Johns Hopkins Bloomberg School of Public Health ### 1393299###Co-Author###Assistant Professor###Johns Hopkins Bloomberg School of Public Health###Co-Author: John W. Jackson, PhD – Johns Hopkins Bloomberg School of Public Health
### @@@ Melissa R. Riester, PharmD – Brown University School of Public Health ### 1302727###Co-Author###Research Scientist###Brown University School of Public Health###Co-Author: Melissa R. Riester, PharmD – Brown University School of Public Health
### @@@ Barbara H. Bardenheier, PhD – Brown University School of Public Health ### 1302731###Co-Author###Assistant Professor###Brown University School of Public Health###Co-Author: Barbara H. Bardenheier, PhD – Brown University School of Public Health
### @@@ Liou Xu, PhD – National Minority Quality Forum ### 1991179###Co-Author######National Minority Quality Forum###Co-Author: Liou Xu, PhD – National Minority Quality Forum
### @@@ Gary Puckrein, PhD – National Minority Quality Forum ### 1991180###Co-Author######National Minority Quality Forum###Co-Author: Gary Puckrein, PhD – National Minority Quality Forum
### @@@ Robertus van Aalst, PhD – Sanofi ### 1302730###Co-Author###Lead, Vaccine Epidemiology and Modeling###Sanofi###Co-Author: Robertus van Aalst, PhD – Sanofi
### @@@ Matthew M. Loiacono, PhD – Sanofi ### 1302734###Co-Author###Medical Evidence Generation Lead###Sanofi###Co-Author: Matthew M. Loiacono, PhD – Sanofi
### @@@ Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health ### 1302736###Co-Author###Associate Professor###Brown University School of Public Health###Co-Author: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
### he/him/hisPresenting Author: Noelle M. Cocoros, DSc, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 1360313###Co-Author###Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
### @@@ John G. Connolly, ScD – Harvard Pilgrim Health Care Institute ### 1063038###Co-Author###Research Scientist###Harvard Pilgrim Health Care Institute###Co-Author: John G. Connolly, ScD – Harvard Pilgrim Health Care Institute
### @@@ Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration ### 1358505###Co-Author###Senior Epidemiologist###US Food and Drug Administration###Co-Author: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
### @@@ Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania ### 1655454###Co-Author######Perelman School of Medicine at the University of Pennsylvania###Co-Author: Dena M. Carbonari, MS – Perelman School of Medicine at the University of Pennsylvania
### @@@ Terese DeFor – HealthPartners Institute ### 1655455###Co-Author######HealthPartners Institute###Co-Author: Terese DeFor – HealthPartners Institute
### @@@ Djeneba Audrey Djibo, PhD – CVS Health ### 1655293###Co-Author###Lead Director - Epidemiology###CVS Health###Co-Author: Djeneba Audrey Djibo, PhD – CVS Health
### @@@ Laura B. Harrington, PhD, MPH – Kaiser Permanente Washington Health Research Institute ### 1360510###Co-Author###Assistant Investigator###Kaiser Permanente Washington Health Research Institute###Co-Author: Laura B. Harrington, PhD, MPH – Kaiser Permanente Washington Health Research Institute
### @@@ Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School ### 1359984###Co-Author###Research Analyst II###Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School###Co-Author: Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
### @@@ Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine ### 1359957###Co-Author###Professor of Epidemiology###University of Pennsylvania Perelman School of Medicine###Co-Author: Sean Hennessy, PharmD, PhD – University of Pennsylvania Perelman School of Medicine
### @@@ Rebecca Hubbard, Ph.D. – University of Pennsylvania ### 1655438###Co-Author###Professor###University of Pennsylvania###Co-Author: Rebecca Hubbard, Ph.D. – University of Pennsylvania
### @@@ Maria Kempner, BA – Harvard Pilgrim Health Care Institute ### 1360312###Co-Author###Senior Research Analyst###Harvard Pilgrim Health Care Institute###Co-Author: Maria Kempner, BA – Harvard Pilgrim Health Care Institute
### @@@ Jennifer Kuntz, PhD – Kaiser Permanente Northwest Center for Health Research ### 1359348###Co-Author######Kaiser Permanente Northwest Center for Health Research###Co-Author: Jennifer Kuntz, PhD – Kaiser Permanente Northwest Center for Health Research
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health Clinical Trial Services###Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health Clinical Trial Services
### @@@ Jolene Mosley – Harvard Pilgrim Health Care Institute ### 1655461###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Jolene Mosley – Harvard Pilgrim Health Care Institute
### @@@ Pamala A. Pawloski, PharmD, BCOP, FCCP – HealthPartners Institute ### 1358149###Co-Author###Senior Research Investigator###HealthPartners Institute###Co-Author: Pamala A. Pawloski, PharmD, BCOP, FCCP – HealthPartners Institute
### @@@ Andrew Petrone, MPH – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA ### 1359985###Co-Author###Lead SAS Programmer/Analyst###Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA###Co-Author: Andrew Petrone, MPH – Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Allyson Pishko – University of Pennsylvania ### 1655462###Co-Author######University of Pennsylvania###Co-Author: Allyson Pishko – University of Pennsylvania
### @@@ Meighan Rogers Driscoll – Harvard Pilgrim Health Care Institute ### 1655463###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Meighan Rogers Driscoll – Harvard Pilgrim Health Care Institute
### @@@ Claudia Steiner, MD MPH – Kaiser Permanente Colorado Institute for Health Research ### 1655464###Co-Author######Kaiser Permanente Colorado Institute for Health Research###Co-Author: Claudia Steiner, MD MPH – Kaiser Permanente Colorado Institute for Health Research
### @@@ Yunping Zhou – Humana Healthcare Research, Inc. ### 1655465###Co-Author######Humana Healthcare Research, Inc.###Co-Author: Yunping Zhou – Humana Healthcare Research, Inc.
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Co-Author###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Co-Author: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/hisIntroducer/Moderator: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Stephen B. Thomas, PhD (he/him/his) – University of Maryland School of Public Health ### 2033612###Speaker###Professor, Health Policy and Management###University of Maryland School of Public Health###Speaker: Stephen B. Thomas, PhD (he/him/his) – University of Maryland School of Public Health
### he/him/his @@@ Paula Braveman, MD, MPH (she/her/hers) – University of California San Francisco ### 2033613###Speaker###Professor, Family Community Medicine###University of California San Francisco###Speaker: Paula Braveman, MD, MPH (she/her/hers) – University of California San Francisco
### she/her/hers @@@ Sieta de Vries, PhD (she/her/hers) – Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen ### 1063125###Speaker###Researcher###Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen###Speaker: Sieta de Vries, PhD (she/her/hers) – Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen
### she/her/hersLead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA
### @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Speaker###Director of Observational Research###Amgen, Inc.###Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Speaker###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Speaker###Associate Director for Science###US Food and Drug Administration###Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hersPresenting Author: Sudhir Venkatesan, MPH, PhD – Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK; Department of Medical Statistics
### @@@ Christen M. Gray – Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK ### 1360359###Co-Author######Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK###Co-Author: Christen M. Gray – Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK
###Presenting Author: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Malcolm Maclure, PhD – University of British Colombia ### 1655849###Co-Author###Professor###University of British Colombia###Co-Author: Malcolm Maclure, PhD – University of British Colombia
### @@@ Suzanne M. Cadarette, PhD – University of Toronto, Toronto, Canada ### 1358519###Co-Author###Associate Professor###University of Toronto, Toronto, Canada###Co-Author: Suzanne M. Cadarette, PhD – University of Toronto, Toronto, Canada
### @@@ Joseph Delaney, PhD – University of Manitoba ### 1359102###Co-Author###Associate Professor###University of Manitoba###Co-Author: Joseph Delaney, PhD – University of Manitoba
### @@@ Heather J. Whitaker – Public Health England ### 1360253###Co-Author###Senior Statistician###Public Health England###Co-Author: Heather J. Whitaker – Public Health England
### @@@ Nicole L. Pratt, FISPE – University of South Australia ### 1358335###Co-Author######University of South Australia###Co-Author: Nicole L. Pratt, FISPE – University of South Australia
### @@@ Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark. ### 1062545###Co-Author###Postdoctoral researcher###Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.###Co-Author: Lars Christian Lund, PhD (he/him/his) – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
### he/him/his